STRONG-HF: Enhancing GDMT regimen in Asia

With 64 million people[1] affected globally, heart failure is a rapidly escalating public health concern, especially critical among over-65s who face high mortality risks. In Asia, the situation is even more pressing, with patients developing heart failure up to a...

Implementation of STRONG-HF protocol in heart failure management: an Australian perspective

Unleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across China

Screening & Diagnosis of Heart Failure in Pre-Diabetic and Diabetic Patients

Elevating CVD management in APAC to its Zenith- with Cardiac biomarkers 

STRONG-HF: Rapid Uptitration of Guideline Directed Medical Therapy for Heart Failure

Guidelines Interpretation – Guidelines for the management of chronic heart failure in dialysis patients in China

Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment

Download APAC STRONG-HF Master Pack: First-hand Insights from Prof Mebazaa on Heart Failure Treatment Monitoring

Heart Failure Management in India – Overcoming Present Challenges

STRONG-HF study highlighting benefits of treatment optimisation

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Uncovering the Cardio-renal Risks of Chinese T2DM patients: Back to the Future with CUHK!

Management of Diabetes in Japan – Can Patients Play a More Significant Role?

T2DM Patient Support Program in Hong Kong and the Value of NT-proBNP

ESC 2021 Heart Failure Guidelines: What’s new?

Heart Failure in Hong Kong- Present Challenges and Future Strategies

Rapid Algorithms for Faster Triage of ED Patients with Suspected AMI – What Are We Waiting For?

Digital Prediction Platforms: A catalyst towards personalized CVD prognosis

CVD Management in T2DM – JCS and JDS Joint Consensus

ESC Recommendation: High sensitivity troponin assay vs conventional assay

ESC Recommendation: Rapid algorithms using hs troponin in ED

How to Implement ESC Rapid Algorithm Successfully?

The Changes in Rapid Algorithms for Acute Coronary Syndrome

Factors affecting high-sensitivity cardiac troponin levels

DAPA-HF and EMPEROR-Reduced Study Highlights

The role of biomarkers in HF

Digital health in HF management

Summary of APSC High Sensitivity Troponin T Consensus

APSC hs-TnT Consensus & Future Use of Biomarker in T2DM & COVID-19

Management of Cardiovascular Risks of COVID-19 Patients

COVID-19 and the Heart, Experience from Front Line

2800+ Healthcare Professionals have cardiac insights delivered to their inbox
Sign up to receive the latest updates via your email
Keep me informed